| Literature DB >> 28852514 |
Amy K Teffer1,2, Scott G Hinch2, Kristi M Miller3, David A Patterson4, Anthony P Farrell5, Steven J Cooke6, Arthur L Bass2, Petra Szekeres6, Francis Juanes1.
Abstract
Bycatch is a common occurrence in heavily fished areas such as the Fraser River, British Columbia, where fisheries target returning adult Pacific salmon (Oncorhynchus spp.) en route to spawning grounds. The extent to which these encounters reduce fish survival through injury and physiological impairment depends on multiple factors including capture severity, river temperature and infectious agents. In an effort to characterize the mechanisms of post-release mortality and address fishery and managerial concerns regarding specific regulations, wild-caught Early Stuart sockeye salmon (Oncorhynchus nerka) were exposed to either mild (20 s) or severe (20 min) gillnet entanglement and then held at ecologically relevant temperatures throughout their period of river migration (mid-late July) and spawning (early August). Individuals were biopsy sampled immediately after entanglement and at death to measure indicators of stress and immunity, and the infection intensity of 44 potential pathogens. Biopsy alone increased mortality (males: 33%, females: 60%) when compared with non-biopsied controls (males: 7%, females: 15%), indicating high sensitivity to any handling during river migration, especially among females. Mortality did not occur until 5-10 days after entanglement, with severe entanglement resulting in the greatest mortality (males: 62%, females: 90%), followed by mild entanglement (males: 44%, females: 70%). Infection intensities of Flavobacterium psychrophilum and Ceratonova shasta measured at death were greater in fish that died sooner. Physiological indicators of host stress and immunity also differed depending on longevity, and indicated anaerobic metabolism, osmoregulatory failure and altered immune gene regulation in premature mortalities. Together, these results implicate latent effects of entanglement, especially among females, resulting in mortality days or weeks after release. Although any entanglement is potentially detrimental, reducing entanglement durations can improve post-release survival.Entities:
Keywords: Bycatch; Pacific salmon; fisheries; gene expression; infectious disease; temperature
Year: 2017 PMID: 28852514 PMCID: PMC5569998 DOI: 10.1093/conphys/cox017
Source DB: PubMed Journal: Conserv Physiol ISSN: 2051-1434 Impact factor: 3.079
Figure 1:British Columbia, Canada and the Fraser River watershed. Early Stuart sockeye enter the Fraser River in early to mid-July, migrating ~1200 km to spawning grounds (dashed circle) in the interior of the province. Fish pass through the Nechako and Stuart rivers before reaching corridor lakes (shown in black, from north to south: Takla, Trembleur and Stuart). Locations of collection (Yale, BC) and experimental holding (DFO Cultus Lake Salmon Research Lab) are shown.
Primer and probe sequences corresponding to stress and immunity biomarkers and three reference genes evaluated via qPCR on adult sockeye salmon (Oncorhynchus nerka).
| Assay name | Gene information | Assay type | EST/Accession# | Primer and probe sequences | Efficiency | Source |
|---|---|---|---|---|---|---|
| B2M | Beta 2-microglobulin | Immune | AF180490 | F—TTTACAGCGCGGTGGAGTC | 0.92 | Haugland |
| R—TGCCAGGGTTACGGCTGTAC | ||||||
| P—AAAGAATCTCCCCCCAAGGTGCAGG | ||||||
| C3 | Complement factor | Immune | U61753, AF271080 | F—ATTGGCCTGTCCAAAACACA | 0.93 | Raida and Buchmann (2009) |
| R—AGCTTCAGATCAAGGAAGAAGTTC | ||||||
| P—TGGAATCTGTGTGTCTGAACCCC | ||||||
| CD4 | Cell receptor | Immune | AY973028 | F—CATTAGCCTGGGTGGTCAAT | 0.83 | Raida and Buchmann (2008) |
| R—CCCTTTCTTTGACAGGGAGA | ||||||
| P—CAGAAGAGAGAGCTGGATGTCTCCG | ||||||
| CD83 | Cell receptor | Immune | AY263794 | F—GATGCACCCCTTGAGAAGAA | 0.76 | Raida |
| R—GAACCCTGTCTCGACCAGTT | ||||||
| P—AATGTTGATTTACACTCTGGGGCCA | ||||||
| Hep | Hepcidin | Immune | AF281354.1 | F—GAGGAGGTTGGAAGCATTGA | 0.82 | Raida and Buchmann (2009) |
| R—TGACGCTTGAACCTGAAATG | ||||||
| P—AGTCCAGTTGGGGAACATCAACAG | ||||||
| IFNa | Interferon-α | Immune | AY216595 | F—CGTCATCTGCAAAGATTGGA | 0.78 | Ingerslev |
| R—GGGCGTAGCTTCTGAAATGA | ||||||
| P—TGCAGCACAGATGTACTGATCATCCA | ||||||
| IgMs | Immunoglobulin | Immune | S63348, AB044939 | F—CTTGGCTTGTTGACGATGAG | 0.79 | Raida |
| R—GGCTAGTGGTGTTGAATTGG | ||||||
| P—TGGAGAGAACGAGCAGTTCAGCA | ||||||
| IL-11 | Cytokine | Immune | AJ535687 | F—GCAATCTCTTGCCTCCACTC | 0.79 | Raida and Buchmann (2008) |
| R—TTGTCACGTGCTCCAGTTTC | ||||||
| P—TCGCGGAGTGTGAAAGGCAGA | ||||||
| IL-15 | Cytokine | Immune | AJ555868.1 | F—TTGGATTTTGCCCTAACTGC | 0.82 | Raida |
| R—CTGCGCTCCAATAAACGAAT | ||||||
| P—CGAACAACGCTGATGACAGGTTTTT | ||||||
| IL-1R | Cytokine | Immune | AJ295296 | F—ATCATCCTGTCAGCCCAGAG | 0.80 | Raida |
| R—TCTGGTGCAGTGGTAACTGG | ||||||
| P—TGCATCCCCTCTACACCCCAAA | ||||||
| IRF1 | Interferon regulatory factor 1 | Immune | CB511515 | F—CAAACCGCAAGAGTTCCTCATT | 0.74 | In house |
| R—AGTTTGGTTGTGTTTTTGCATGTAG | ||||||
| P—CTGGCGCAGCAGATA | ||||||
| MHCI | Major histocompatibility complex I | Immune | F—GCGACAGGTTTCTACCCCAGT | 0.81 | ||
| R—TGTCAGGTGGGAGCTTTTCTG | ||||||
| P—TGGTGTCCTGGCAGAAAGACGG | ||||||
| MHCII-B | Major histocompatibility complex IIβ | Immune | AF115533 | F—TGCCATGCTGATGTGCAG | 0.80 | |
| R—GTCCCTCAGCCAGGTCACT | ||||||
| P—CGCCTATGACTTCTACCCCAAACAAAT | ||||||
| MMP13 | Matrix metalloproteinase | Immune | 213514499 | F—GCCAGCGGAGCAGGAA | 0.81 | |
| R—AGTCACCTGGAGGCCAAAGA | ||||||
| P—TCAGCGAGATGCAAAG | ||||||
| Mx | Antiviral protein | Immune | F—AGATGATGCTGCACCTCAAGTC | 0.81 | ||
| R—CTGCAGCTGGGAAGCAAAC | ||||||
| P—ATTCCCATGGTGATCCGCTACCTGG | ||||||
| RIG-I | Retinoic acid inducible gene I | Immune | NM_001163699 | F—ACAGCTGTTACACAGACGACATCA | 0.81 | |
| R—TTTAGGGTGAGGTTCTGTCCGA | ||||||
| P—TCGTGTTGGACCCCACTCTGTTCTCTC | ||||||
| SHOP21 | Salmon hyperosmotic protein 21 | Immune | CA054269 | F—GCGGTAGTGGAGTCAGTTGGA | 0.76 | In house |
| R—GCTGCTGACGTCTCACATCAC | ||||||
| P—CCTGTTGATGCTCAAGG | ||||||
| TF | Transferrin | Immune | D89083 | F—TTCACTGCTGGAAAATGTGG | 0.81 | |
| R—GCTGCACTGAACTGCATCAT | ||||||
| P—TGGTCCCTGTCATGGTGGAGCA | ||||||
| ATP5G3-C | ATP synthase | MRS | CB493164 | F—GGAACGCCACCATGAGACA | 0.79 | In house |
| R—CGCCATCCTGGGCTTTG | ||||||
| P—AGCCCCATTGCCTC | ||||||
| C4B | Complement factor | MRS | CB518123 | F—TCCAACCACATCGCATTATCC | 0.73 | In house |
| R—ATCTCTGACACCACTGACCACAA | ||||||
| P—ATAGACAGGCTTCCC | ||||||
| C7 | Complement factor | MRS | CA052045 | F—ACCTCTGTCCAGCTCTGTGTC | 0.84 | In house |
| R—GATGCTGACCACATCAAACTGC | ||||||
| P—AACTACCAGACAGTGCTG | ||||||
| EIF4E | Initiation factor | MRS | CA051191, CB496372 | F—TCTGGAAACCCACACACAAAGA | 1.00 | In house |
| R—GCGTTTTGAGGTTTGCATGTT | ||||||
| P—CCTGCCATAGCCACAC | ||||||
| KCTD1 | Potassium channel tetramerization domain | MRS | CA062065 | F—TGTTTGTTAAAAGGGGACACAGTG | 0.88 | In house |
| R—GTGAAGTGTTATCTGGGCTGAAAG | ||||||
| P—CTCCAAGGCTGAAAT | ||||||
| MCSF | Macrophage colony stimulating factor | MRS | CA061415 | F—GCTCTCTCAATCCTTGGCTTTAC | 0.85 | In house |
| R—ACCAGCATAATTGAAAACCAGAGG | ||||||
| P—CTCAATGTCCTCAATGCT | ||||||
| GR-2 | Glucocorticoid receptor | Stress | F—TCCAGCAGCTATGCCAGTTCT | 0.84 | ( | |
| R—TTGCCCTGGGTTGTACATGA | ||||||
| P—AAGCTTGGTGGTGGCGCTG | ||||||
| HSC70 | Heat shock cognate 70 | Stress | CA052185 | F—GGGTCACACAGAAGCCAAAAG | 0.75 | In house |
| R—GCGCTCTATAGCGTTGATTGGT | ||||||
| P—AGACCAAGCCTAAACTA | ||||||
| Hsp90 | Heat shock protein 90 | Stress | CB493960, CB503707 | F—TGGGCTACATGGCTGCCAAG | 0.80 | In house |
| R—TCCAAGGTGAACCCAGAGGAC | ||||||
| P—AGCACCTGGAGATCAA | ||||||
| JUN | Transcription factor | Stress | CA056351 | F—TTGTTGCTGGTGAGAAAACTCAGT | 0.79 | In house |
| R—CCTGTTGCCCTATGAATTGTCTAGT | ||||||
| P—AGACTTGGGCTATTTAC | ||||||
| 78d16.1 | Reference | CA056739 | F—GTCAAGACTGGAGGCTCAGAG | 0.84 | In house | |
| R—GATCAAGCCCCAGAAGTGTTTG | ||||||
| P—AAGGTGATTCCCTCGCCGTCCGA | ||||||
| COIL-P84-2 | Reference | CA053789 | F—GCTCATTTGAGGAGAAGGAGGATG | 0.83 | In house | |
| R—CTGGCGATGCTGTTCCTGAG | ||||||
| P—TTATCAAGCAGCAAGCC | ||||||
| MRPL40 | Reference | CK991258 | F—CCCAGTATGAGGCACCTGAAGG | 0.76 | In house | |
| R—GTTAATGCTGCCACCCTCTCAC | ||||||
| P—ACAACAACATCACCA |
Assay type classifies genes by their association with immunity, stress or a mortality-related signature (MRS) predictive of migration failure of wild salmon (Miller ). References and average qPCR efficiencies are provided; in-house designs were conducted by the Molecular Genetics Laboratory at the Pacific Biological Station, Nanaimo, BC.
Abbreviations, names and types of microbes suspected or known to cause disease in Pacific salmon in British Columbia, Canada, evaluated via qPCR on adult sockeye salmon (Oncorhynchus nerka)
| Assay abbreviation | Microbe full name | Type | Prevalence | Prevalence at spawning grounds | Primer and probe sequences | Efficiency | Reference |
|---|---|---|---|---|---|---|---|
| ae_hyd | Bacterium | 1 | 15 | F—ACCGCTGCTCATTACTCTGATG | 0.91 | ||
| R—CCAACCCAGACGGGAAGAA | |||||||
| P—TGATGGTGAGCTGGTTG | |||||||
| ae_sal | Bacterium | 0 | 0 | F—TAAAGCACTGTCTGTTACC | 0.96 | ||
| R—GCTACTTCACCCTGATTGG | |||||||
| P—ACATCAGCAGGCTTCAGAGTCACTG | |||||||
| re_sal | Bacterium | 0 | 0 | F—CAACAGGGTGGTTATTCTGCTTTC | 0.93 | ||
| R—CTATAAGAGCCACCAGCTGCAA | |||||||
| P—CTCCAGCGCCGCAGGAGGAC | |||||||
| c_b_cys | Bacterium | 96 | 100 | F—AATACATCGGAACGTGTCTAGTG | 0.90 | ||
| R—GCCATCAGCCGCTCATGTG | |||||||
| P—CTCGGTCCCAGGCTTTCCTCTCCCA | |||||||
| ye_ruc | Bacterium | 0 | 0 | F—TGCCGCGTGTGTGAAGAA | 0.93 | ||
| R—ACGGAGTTAGCCGGTGCTT | |||||||
| P—AATAGCACTGAACATTGAC | |||||||
| fl_psy | Bacterium | 55 | 100 | F—GATCCTTATTCTCACAGTACCGTCAA | 0.80 | ||
| R—TGTAAACTGCTTTTGCACAGGAA | |||||||
| P—AAACACTCGGTCGTGACC | |||||||
| pch_sal | Bacterium | 0 | 0 | F—TCACCCCCAGGCTGCTT | 0.87 | ||
| R—GAATTCCATTTCCCCCTCTTG | |||||||
| P—CAAAACTGCTAGACTAGAGT | |||||||
| pisck_sal | Bacterium | 0 | 0 | F—TCTGGGAAGTGTGGCGATAGA | 0.95 | ||
| R—TCCCGACCTACTCTTGTTTCATC | |||||||
| P—TGATAGCCCCGTACACGAAACGGCATA | |||||||
| rlo | Bacterium | 78 | 69 | F—GGCTCAACCCAAGAACTGCTT | 0.89 | ||
| R—GTGCAACAGCGTCAGTGACT | |||||||
| P—CCCAGATAACCGCCTTCGCCTCCG | |||||||
| sch | Bacterium | 0 | 0 | F—GGGTAGCCCGATATCTTCAAAGT | 0.95 | ||
| R—CCCATGAGCCGCTCTCTCT | |||||||
| P—TCCTTCGGGACCTTAC | |||||||
| vi_ang | Bacterium | 0 | 0 | F—CCGTCATGCTATCTAGAGATGTATTTGA | 0.96 | In house | |
| R—CCATACGCAGCCAAAAATCA | |||||||
| P—TCATTTCGACGAGCGTCTTGTTCAGC | |||||||
| vi_sal | Bacterium | 0 | 0 | F—GTGTGATGACCGTTCCATATTT | 0.91 | In house | |
| R—GCTATTGTCATCACTCTGTTTCTT | |||||||
| P—TCGCTTCATGTTGTGTAATTAGGAGCGA | |||||||
| aspv | Atlantic salmon paramyxovirus | Virus | 0 | 0 | F—CCCATATTAGCAAATGAGCTCTATCTT | 0.92 | |
| R—CGTTAAGGAACTCATCATTGAGCTT | |||||||
| P—AGCCCTTTTGTTCTGC | |||||||
| pmcv | Piscine totivirus (CMS) | Virus | 4 | 15 | F—TTCCAAACAATTCGAGAAGCG | 0.92 | |
| R—ACCTGCCATTTTCCCCTCTT | |||||||
| P—CCGGGTAAAGTATTTGCGTC | |||||||
| ver | Viral encephalopathy and retinopathy virus | Virus | 0 | 0 | F—TTCCAGCGATACGCTGTTGA | 1.02 | |
| R—CACCGCCCGTGTTTGC | |||||||
| P—AAATTCAGCCAATGTGCCCC | |||||||
| vhsv | Viral haemorrhagic septicaemia virus | Virus | 0 | 0 | F—ATGAGGCAGGTGTCGGAGG | 0.86 | |
| R—TGTAGTAGGACTCTCCCAGCATCC | |||||||
| P—TACGCCATCATGATGAGT | |||||||
| omv | Salmonid herpesvirus | Virus | 0 | 0 | F—GCCTGGACCACAATCTCAATG | 0.95 | In house |
| R—CGAGACAGTGTGGCAAGACAAC | |||||||
| P—CCAACAGGATGGTCATTA | |||||||
| sav | Salmon alphavirus | Virus | 0 | 0 | F—CCGGCCCTGAACCAGTT | 0.99 | |
| R—GTAGCCAAGTGGGAGAAAGCT | |||||||
| P—TCGAAGTGGTGGCCAG | |||||||
| ven | Viral erythrocytic necrosis virus | Virus | 0 | 0 | F—CGTAGGGCCCCAATAGTTTCT | 0.96 | James Winton, pers. comm. |
| R—GGAGGAAATGCAGACAAGATTTG | |||||||
| P—TCTTGCCGTTATTTCCAGCACCCG | |||||||
| pspv | Pacific salmon parvovirus | Virus | 0 | 0 | F—CCCTCAGGCTCCGATTTTTAT | NA | In house |
| R—CGAAGACAACATGGAGGTGACA | |||||||
| P—CAATTGGAGGCAACTGTA | |||||||
| prv | Piscine reovirus (HSMI, CMS) | Virus | 0 | 0 | F—TGCTAACACTCCAGGAGTCATTG | 0.85 | |
| R—TGAATCCGCTGCAGATGAGTA | |||||||
| P—CGCCGGTAGCTCT | |||||||
| ihnv | Infectious haematopoietic necrosis virus | Virus | 0 | 0 | F—AGAGCCAAGGCACTGTGCG | 0.87 | |
| R—TTCTTTGCGGCTTGGTTGA | |||||||
| P—TGAGACTGAGCGGGACA | |||||||
| cr_sal | Parasite | 0 | 15 | F—TCAGTGCCTTTCAGGACATC | 0.89 | In house | |
| R—GAGGCATCCACTCCAATAGAC | |||||||
| P—AGGAGGACATGGCAGCCTTTGTAT | |||||||
| ce_sha | Parasite | 96 | 85 | F—CCAGCTTGAGATTAGCTCGGTAA | 0.93 | ||
| (formerly | R—CCCCGGAACCCGAAAG | ||||||
| P—CGAGCCAAGTTGGTCTCTCCGTGAAAAC | |||||||
| de_sal | Parasite | 1 | 0 | F—CAGCCAATCCTTTCGCTTCT | 0.90 | In house | |
| R—GACGGACGCACACCACAGT | |||||||
| P—AAGCGGCGTGTGCC | |||||||
| fa_mar | Parasite | 1 | 0 | F—AGGAAGGAGCACGCAAGAAC | 0.92 | In house | |
| R—CGCGTGCAGCCCAGTAC | |||||||
| P—TCAGTGATGCCCTCAGA | |||||||
| gy_sal | Parasite | 0 | 0 | F—CGATCGTCACTCGGAATCG | 0.89 | ||
| R—GGTGGCGCACCTATTCTACA | |||||||
| P—TCTTATTAACCAGTTCTGC | |||||||
| ic_mul | Parasite | 83 | 100 | F—AAATGGGCATACGTTTGCAAA | 0.9 | In house | |
| R—AACCTGCCTGAAACACTCTAATTTTT | |||||||
| P—ACTCGGCCTTCACTGGTTCGACTTGG | |||||||
| ku_thy | Parasite | 10 | 23 | F—TGGCGGCCAAATCTAGGTT | 0.91 | ||
| R—GACCGCACACAAGAAGTTAATCC | |||||||
| P—TATCGCGAGAGCCGC | |||||||
| lo_sal | Parasite | 79 | 77 | F—GGAGTCGCAGCGAAGATAGC | 0.93 | In house | |
| R—CTTTTCCTCCCTTTACTCATATGCTT | |||||||
| P—TGCCTGAAATCACGAGAGTGAGACTACCC | |||||||
| my_arc | Parasite | 18 | 23 | F—TGGTAGATACTGAATATCCGGGTTT | 0.89 | In house | |
| R—AACTGCGCGGTCAAAGTTG | |||||||
| P—CGTTGATTGTGAGGTTGG | |||||||
| my_ins | Parasite | 0 | 0 | F—CCAATTTGGGAGCGTCAAA | 0.83 | In house | |
| R—CGATCGGCAAAGTTATCTAGATTCA | |||||||
| P—CTCTCAAGGCATTTAT | |||||||
| my_cer | Parasite | 0 | 0 | F—GCCATTGAATTTGACTTTGGATTA | 0.99 | ||
| R—ACCATTCATGTAAGCCCGAACT | |||||||
| P—TCGAAGCCTTGACCATCTTTTGGCC | |||||||
| ne_per | Parasite | 0 | 0 | F—GTTCTTTCGGGAGCTGGGAG | 1.05 | ||
| R—GAACTATCGCCGGCACAAAAG | |||||||
| P—CAATGCCATTCTTTTCGGA | |||||||
| nu_sal | Parasite | 0 | 0 | F—GCCGCAGATCATTACTAAAAACCT | 0.94 | ||
| R—CGATCGCCGCATCTAAACA | |||||||
| P—CCCCGCGCATCCAGAAATACGC | |||||||
| pa_ther | Parasite | 13 | 23 | F—CGGACAGGGAGCATGGTATAG | 0.92 | ||
| R—GGTCCAGGTTGGGTCTTGAG | |||||||
| P—TTGGCGAAGAATGAAA | |||||||
| pa_pse | Parasite | 0 | 0 | F—CAGCTCCAGTAGTGTATTTCA | 0.95 | ||
| R—TTGAGCACTCTGCTTTATTCAA | |||||||
| P—CGTATTGCTGTCTTTGACATGCAGT | |||||||
| pa_kab | Parasite | 2 | 8 | F—GTCGGATGATAAGTGCATCTGATT | 0.97 | In house | |
| R—ACACCACAACTCTGCCTTCCA | |||||||
| P—TGCGACCATCTGCACGGTACTGC | |||||||
| te_bry | Parasite | 4 | 85 | F—GCGAGATTTGTTGCATTTAAAAAG | 0.89 | ||
| R—GCACATGCAGTGTCCAATCG | |||||||
| P—CAAAATTGTGGAACCGTCCGACTACGA | |||||||
| pa_min | Parasite | 100 | 100 | F—AATAGTTGTTTGTCGTGCACTCTGT | 0.88 | ||
| R—CCGATAGGCTATCCAGTACCTAGTAAG | |||||||
| P—TGTCCACCTAGTAAGGC | |||||||
| sp_des | Parasite | 1 | 23 | F—GCCGCGAGGTGTTTGC | 0.89 | In house | |
| R—CTCGACGCACACTCAATTAAGC | |||||||
| P—CGAGGGTATCCTTCCTCTCGAAATTGGC | |||||||
| sp_sal | Parasite | 0 | 0 | F—AACCGGTTATTCGTGGGAAAG | 0.91 | In house | |
| R—TTAACTGCAGCAACACAATAGAATACTC | |||||||
| P—TGCCAGCAGCCGCGGTAATTC | |||||||
| ic_hof | Parasite | 0 | 0 | F—GTCTGTACTGGTACGGCAGTTTC | 0.91 | ||
| R—TCCCGAACTCAGTAGACACTCAA | |||||||
| P—TAAGAGCACCCACTGCCTTCGAGAAGA | |||||||
| na_sal | Fluke | 0 | 0 | F—CGATCTGCATTTGGTTCTGTAACA | 0.88 | In house | |
| R—CCAACGCCACAATGATAGCTATAC | |||||||
| P—TGAGGCGTGTTTTATG |
Prevalence values describe percent positive detections among Early Stuart sockeye collected in the Fraser River at Yale, BC (n = 107; includes individuals sacrificed river-side at collection and those held for up to 40 days) and among those sacrificed at spawning grounds (n = 13; near Takla Lake, 7–8 August 2013). Primer and probe sequences with references and qPCR efficiencies are provided; in-house designs were conducted by the Molecular Genetics Laboratory at the Pacific Biological Station, Nanaimo, BC.
Variables included in the multivariate classification tree analysis using survival to the spawning period of Early Stuart sockeye (>20 days post-treatment) as the grouping factor
| Type | Variables |
|---|---|
| Environmental/morphological | Gillnet exposure time, sex, total condition score, length, stock |
| Microbes | c_b_cys, ce_sha, fl_psy, ic_mul, lo_sal, pa_min, rlo |
| Gene expression biomarkers of stress and immunity | ATP5G3C, B2M, C3, C4B, C7, CD4, CD83, EIF4E, GR2, hep, HSC70, Hsp90, IFNa, IgMs, IL11, IL15, IL1R, IRF1, JUN, KCTD1, MCSF, MHCI, MHCIIB, MMP13, Mx, RIGI, SHOP21, TF |
| Clinical variables (hormones, metabolites, ions and other physiological indicators) | Chloride, osmolality, sodium, potassium, muscle lipid, cortisol, oestradiol, testosterone, glucose, lactate, haematocrit, leucocrit |
Full microbe names can be found in Table 2.
Figure 2:Kaplan–Meier survival curves are shown for female (a) and male (b) Early Stuart sockeye exposed to severe gillnet entanglement (20 min plus 1 min air exposure, n = 26; solid), mild gillnet entanglement (20 s plus 1 min air, n = 26; dashed), biopsied controls (n = 14; dot-dashed) and non-biopsied controls (n = 27; dotted). Triangles are censored data points. The grey shaded area corresponds to the spawning period of this population including nest defence. The red shaded area shows the temperature (°C) of all holding tanks through course of the study, which follows the modelled thermal experience of an Early Stuart sockeye migrant in the Fraser River in 2014. Daily hazard ratios for females (c) and males (d) are plotted as a function of time (all treatments combined) with a solid line lowess smoothing function. Hazard ratios correspond to the number of mortalities divided by the total survivors on each day the mortality occurred.
Sample sizes (n), mean days surviving (±standard error) and percent mortality prior to the spawning period (20 days post-treatment) for female (F) and male (M) Early Stuart sockeye salmon by treatment
| Days surviving | Mortality prior to spawning period | |||||
|---|---|---|---|---|---|---|
| F | M | F | M | F (%) | M (%) | |
| Severe gillnet | 10 | 16 | 9.4 ± 1.8 | 16.3 ± 2.8 | 90 | 62 |
| Mild gillnet | 10 | 16 | 17.0 ± 2.8 | 24.4 ± 2.7 | 70 | 44 |
| Biopsied control | 5 | 9 | 23.4 ± 3.5 | 29.6 ± 2.9 | 60 | 33 |
| Control | 13 | 14 | 31.2 ± 2.4 | 36.0 ± 1.2 | 15 | 7 |
| Total | 38 | 55 | 20.7 ± 1.5 | 25.9 ± 1.4 | 55 | 38 |
Figure 3:Box plots illustrating blood plasma indices of maturation (oestradiol and testosterone), metabolic stress (glucose, cortisol, lactate, haematocrit), and osmoregulatory and ionic imbalance (osmolality, potassium, chloride, sodium) measured in Early Stuart sockeye at the time of gillnet capture (T0; n = 19) and 2 days following gillnet capture (T1; n = 28). Oestradiol, testosterone, cortisol and glucose models included a significant sex factor showing differential changes for females (pink) and males (blue) at each time point. Letters at the top right of each plot denote significant differences (P < 0.05) between timepoints (T), sexes (S) or an interaction between the terms (S × T).
Figure 4: (a)PC analysis of gene expression in gill tissue (28 biomarkers of stress and immunity) at the time of gillnet capture (T0; orange) and 2 days following capture (T1; blue). Ellipses represent 95% confidence intervals for each group cluster. (b) PC loadings of genomic biomarker variables.
Figure 5:Beanplots of microbe productivity (log RNA copy number) at the time of gillnet capture (T0, n = 19; black) and 2 days following gillnet capture (T1, n = 22; grey) of Early Stuart sockeye in the Fraser River in Yale, BC. Polygons represent non-parametric density estimates, white bars represent total samples corresponding to RNA productivity, solid black bars represent the median productivity per time point (including negative detections) and dotted lines mark the overall median productivity. Significant differences in prevalence (P < 0.05) were identified for Flavobacterium psychrophilum and Loma salmonae, while Ceratonova shasta productivity differed between time points. Only microbes with sufficient total positive samples in one or both groups could be included in the analysis. Microbe productivities were measured from a small gill tissue biopsy (2–3 filament tips), normalized to 0.5 μg/μl of RNA per sample after RNA purification.
Figure 6:Three examples of Early Stuart sockeye exposed to experimental gillnet entanglement: (a) a prematurely moribund male showing severe necrosis and Saprolegnia spp. fungal infections, (b) a surviving male lacking secondary sexual characteristics and mild gillnet scarring posterior to the operculum and (c) a surviving male with well-developed secondary sexual characteristics and ventral gillnet scarring anterior to the dorsal fin.
Figure 7:Relative productivity (log RNA copy number) of Flavobacterium psychrophilum, Ceratonova shasta, Ichthyophthirius multifiliis, Rickettsia-like organism, Loma salmonae, Candidatus Branchiomonas cysticola and Parvicapsula minibicornis as a function of days surviving for adult Early Stuart sockeye salmon. Each point represents the microbe burden of an individual at death; colour corresponds to treatment, with severe (20 min) entanglement in black, mild entanglement (20 s) in dark blue, biopsied controls in light blue and non-biopsied controls in white. Screening for microbes was conducted using a pool of aqueous phase from seven homogenized tissues including gill, liver, spleen, head kidney, heart, white muscle and brain (alternated every other individual). All relationships (linear models on positive detections) were significant (P < 0.05), except for L. salmonae (P = 0.97); model parameters can be found in the text.
Agreement between gill and pooled tissues in quantification of presence and relative productivities
| Microbe | Abbreviation | Agreement between gill and pooled tissues (%) | Linear regression of positives | Breusch–Pagan test | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total agreement | Gill + Pool + | Gill −Pool − | Gill + Pool − | Gill −Pool + | BP | ||||||
| ae_sal | 99 | 1 | 98 | 0 | 1 | NA | NA | NA | NA | NA | |
| c_b_cys | 98 | 95 | 2 | 1 | 1 | 0.29 | 0.81 | <0.01 | 28.5 | <0.01 | |
| ce_sha | 69 | 66 | 2 | 0 | 31 | 0.06 | 0.01 | 0.51 | 0.3 | 0.59 | |
| cr_sal | 98 | 0 | 98 | 0 | 2 | NA | NA | NA | NA | NA | |
| de_sal | 99 | 0 | 99 | 1 | 0 | NA | NA | NA | NA | NA | |
| fl_psy | 84 | 49 | 35 | 1 | 14 | 0.29 | 0.97 | <0.01 | 3.2 | 0.08 | |
| ic_mul | 94 | 75 | 19 | 1 | 5 | 0.45 | 0.74 | <0.01 | 25.1 | <0.01 | |
| ku_thy | 98 | 11 | 87 | 0 | 2 | 0.22 | 0.29 | 0.13 | 0.6 | 0.43 | |
| lo_sal | 80 | 65 | 14 | 4 | 17 | 0.33 | 0.90 | <0.01 | 25.7 | <0.01 | |
| pa_min | 99 | 99 | 0 | 0 | 1 | 0.23 | 0.55 | <0.01 | 14.8 | <0.01 | |
| rlo | 99 | 67 | 31 | 0 | 1 | 0.43 | 0.83 | <0.01 | 16.9 | <0.01 | |
| sp_des | 95 | 0 | 95 | 2 | 2 | NA | NA | NA | NA | NA | |
| te_bry | 94 | 8 | 86 | 0 | 6 | 0.43 | 0.44 | 0.11 | 0.5 | 0.46 | |
Total agreement and sources of error in presence/absence of data are shown as percents; relationships between calculated productivities are shown as the slope (β), r2 and P-values from linear regression of gill and pooled values (predictor and response, respectively). Breusch–Pagan tests describe the heteroscedasticity of the linear relationships. Only positive values were included in the linear regression models.
Figure 8:NNMDS plot of microbe productivities within the pooled tissues (gill, liver, spleen, heart, kidney, muscle, brain) of 42 Early Stuart sockeye. Vectors represent correlated (P < 0.10) host gene expression and plasma/muscle biomarkers of stress, condition and immunity. Shapes designate sex (filled circles = females, filled triangles = males) and colour represents the severity of handling and experimental gillnet treatment, with lightest to darkest as non-biopsied controls, biopsied controls, 20-s gillnet-treated, and 20-min gillnet-treated fish, respectively. The size of points represents longevity, with the largest points living the longest.